Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Ursodeoxycholic Acid Market

Ursodeoxycholic Acid Market Share

Report ID: GMI6838
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Ursodeoxycholic Acid Market Share

Major market players operating in the UDCA market is as mentioned below:

ICE S.p.a.
Merck KGa
Daewoong Bio
Glenmark Pharmaceuticals Ltd
Dipharma Francis S.r.l.
IOL Chemicals and Pharmaceuticals
Kimia Biosciences Ltd
Cerata Pharmaceuticals
Changde Yungang Biotechnology Co. Ltd.
Osmopharm SA
Tianjin NWS Biotechnology and Medicine Co. Ltd
Zhongshan Belling Biotechnology Co. Ltd.
Axplora
Anant Pharmaceuticals Pvt Ltd

The global ursodeoxycholic acid market is highly competitive and consists of several major players. ICE s.p.a., Merck KGa, and Daewoong Bio accounts for largest market share in the overall ursodeoxycholic acid API market. These market players are engaged in strategic collaborations, partnerships, mergers, etc., to maintain their position in the market, capture the highest market share, and outperform the competition. By meticulously assessing the market share of each company, considering factors such as product offerings, production capacity, geographic reach, etc., one can unveil valuable insights into the competitive landscape of its market and strategically position themselves for success in this sector.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ursodeoxycholic acid industry size reached USD 581.7 million in 2022 and is poised to reach USD 1.4 billion by 2032 attributed to the increasing prevalence of liver diseases, such as primary biliary cholangitis and gallstones.

Synthetic segment is expected to be worth USD 958.6 million by 2032 driven by widespread utilization in the pharmaceutical and medical fields for its multitude advantages.

North America ursodeoxycholic acid market accounted for USD 203.7 million in revenue in 2022 and is expected to expand at notable CAGR through 2032 owing to increasing application due to the elevated prevalence of liver and gallbladder ailments UDCA.

Some of the top ursodeoxycholic acid companies are Daewoong Bio, ICE S.p.a., Merck KGa, Glenmark Pharmaceuticals Ltd., Dipharma Francis S.r.l., IOL Chemicals and Pharmaceuticals, Kimia Biosciences Ltd., Cerata Pharmaceuticals, and Changde Yungang Biotechnology Co. Ltd.,